Document published by the source itself

EP49 | Framework for Developing Evidence of Clinical Validity of Medical Laboratory Test Methods

CLSI’s framework for building evidence of clinical validity, written for manufacturers and for labs developing their own tests.

Technical guidanceCLSIFirst Edition; Date of Publication March 19, 2026

Source

CLSI EP49 provides a framework to aid test developers (both manufacturers and laboratories that create laboratory-developed tests [LDTs]) in establishing evidence of clinical validity for medical laboratory test methods using noninterventional clinical performance studies.

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Key takeaways

CLSI’s framework for building evidence of clinical validity, written for manufacturers and for labs developing their own tests.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-09

Updated

2026-10-09

Disclaimer

professional use

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.